Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection

Dorothea Morris, Maria Ansar, Janice Speshock, Teodora Ivanciuc, Yue Qu, Antonella Casola, Roberto Garofalo

Research output: Contribution to journalArticle

Abstract

Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infection in children for which no specific treatment option is available. The RSV virion contains two surface glycoproteins (F and G) that are vital for the initial phases of infection, making them critical targets for RSV therapeutics. Recent studies have identified the broad-spectrum antiviral properties of silver nanoparticles (AgNPs) against respiratory pathogens, such as adenovirus, parainfluenza, and influenza. AgNPs achieve this by attaching to viral glycoproteins, blocking entry into the host cell. The objective of this study was to evaluate the antiviral and immunomodulatory effects of AgNPs in RSV infection. Herein we demonstrate AgNP-mediated reduction in RSV replication, both in epithelial cell lines and in experimentally infected BALB/c mice. Marked reduction in pro-inflammatory cytokines (i.e., IL-1α, IL-6, TNF-α) and pro-inflammatory chemokines (i.e., CCL2, CCL3, CCL5) was also observed. Conversely, CXCL1, G-CSF, and GM-CSF were increased in RSV-infected mice treated with AgNPs, consistent with an increase of neutrophil recruitment and activation in the lung tissue. Following experimental antibody-dependent depletion of neutrophils, the antiviral effect of AgNPs in mice treated was ablated. To our knowledge, this is the first in vivo report demonstrating antiviral activity of AgNPs during RSV infection.

Original languageEnglish (US)
Article number732
JournalViruses
Volume11
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Respiratory Syncytial Viruses
Silver
Nanoparticles
Antiviral Agents
Respiratory Syncytial Virus Infections
Infection
Granulocyte-Macrophage Colony-Stimulating Factor
Paramyxoviridae Infections
Neutrophil Activation
Neutrophil Infiltration
Chemokine CCL2
Membrane Glycoproteins
Granulocyte Colony-Stimulating Factor
Virus Replication
Interleukin-1
Adenoviridae
Respiratory Tract Infections
Virion
Human Influenza
Interleukin-6

Keywords

  • AgNP
  • Anti-Ly6G
  • Antiviral
  • Epithelial cells
  • G-CSF
  • GM-CSF
  • KC
  • Neutrophils
  • Respiratory syncytial virus
  • Silver nanoparticles

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection. / Morris, Dorothea; Ansar, Maria; Speshock, Janice; Ivanciuc, Teodora; Qu, Yue; Casola, Antonella; Garofalo, Roberto.

In: Viruses, Vol. 11, No. 8, 732, 01.08.2019.

Research output: Contribution to journalArticle

Morris, Dorothea ; Ansar, Maria ; Speshock, Janice ; Ivanciuc, Teodora ; Qu, Yue ; Casola, Antonella ; Garofalo, Roberto. / Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection. In: Viruses. 2019 ; Vol. 11, No. 8.
@article{d370d469230b45268fcf78b678c8a072,
title = "Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection",
abstract = "Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infection in children for which no specific treatment option is available. The RSV virion contains two surface glycoproteins (F and G) that are vital for the initial phases of infection, making them critical targets for RSV therapeutics. Recent studies have identified the broad-spectrum antiviral properties of silver nanoparticles (AgNPs) against respiratory pathogens, such as adenovirus, parainfluenza, and influenza. AgNPs achieve this by attaching to viral glycoproteins, blocking entry into the host cell. The objective of this study was to evaluate the antiviral and immunomodulatory effects of AgNPs in RSV infection. Herein we demonstrate AgNP-mediated reduction in RSV replication, both in epithelial cell lines and in experimentally infected BALB/c mice. Marked reduction in pro-inflammatory cytokines (i.e., IL-1α, IL-6, TNF-α) and pro-inflammatory chemokines (i.e., CCL2, CCL3, CCL5) was also observed. Conversely, CXCL1, G-CSF, and GM-CSF were increased in RSV-infected mice treated with AgNPs, consistent with an increase of neutrophil recruitment and activation in the lung tissue. Following experimental antibody-dependent depletion of neutrophils, the antiviral effect of AgNPs in mice treated was ablated. To our knowledge, this is the first in vivo report demonstrating antiviral activity of AgNPs during RSV infection.",
keywords = "AgNP, Anti-Ly6G, Antiviral, Epithelial cells, G-CSF, GM-CSF, KC, Neutrophils, Respiratory syncytial virus, Silver nanoparticles",
author = "Dorothea Morris and Maria Ansar and Janice Speshock and Teodora Ivanciuc and Yue Qu and Antonella Casola and Roberto Garofalo",
year = "2019",
month = "8",
day = "1",
doi = "10.3390/v11080732",
language = "English (US)",
volume = "11",
journal = "Viruses",
issn = "1999-4915",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection

AU - Morris, Dorothea

AU - Ansar, Maria

AU - Speshock, Janice

AU - Ivanciuc, Teodora

AU - Qu, Yue

AU - Casola, Antonella

AU - Garofalo, Roberto

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infection in children for which no specific treatment option is available. The RSV virion contains two surface glycoproteins (F and G) that are vital for the initial phases of infection, making them critical targets for RSV therapeutics. Recent studies have identified the broad-spectrum antiviral properties of silver nanoparticles (AgNPs) against respiratory pathogens, such as adenovirus, parainfluenza, and influenza. AgNPs achieve this by attaching to viral glycoproteins, blocking entry into the host cell. The objective of this study was to evaluate the antiviral and immunomodulatory effects of AgNPs in RSV infection. Herein we demonstrate AgNP-mediated reduction in RSV replication, both in epithelial cell lines and in experimentally infected BALB/c mice. Marked reduction in pro-inflammatory cytokines (i.e., IL-1α, IL-6, TNF-α) and pro-inflammatory chemokines (i.e., CCL2, CCL3, CCL5) was also observed. Conversely, CXCL1, G-CSF, and GM-CSF were increased in RSV-infected mice treated with AgNPs, consistent with an increase of neutrophil recruitment and activation in the lung tissue. Following experimental antibody-dependent depletion of neutrophils, the antiviral effect of AgNPs in mice treated was ablated. To our knowledge, this is the first in vivo report demonstrating antiviral activity of AgNPs during RSV infection.

AB - Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infection in children for which no specific treatment option is available. The RSV virion contains two surface glycoproteins (F and G) that are vital for the initial phases of infection, making them critical targets for RSV therapeutics. Recent studies have identified the broad-spectrum antiviral properties of silver nanoparticles (AgNPs) against respiratory pathogens, such as adenovirus, parainfluenza, and influenza. AgNPs achieve this by attaching to viral glycoproteins, blocking entry into the host cell. The objective of this study was to evaluate the antiviral and immunomodulatory effects of AgNPs in RSV infection. Herein we demonstrate AgNP-mediated reduction in RSV replication, both in epithelial cell lines and in experimentally infected BALB/c mice. Marked reduction in pro-inflammatory cytokines (i.e., IL-1α, IL-6, TNF-α) and pro-inflammatory chemokines (i.e., CCL2, CCL3, CCL5) was also observed. Conversely, CXCL1, G-CSF, and GM-CSF were increased in RSV-infected mice treated with AgNPs, consistent with an increase of neutrophil recruitment and activation in the lung tissue. Following experimental antibody-dependent depletion of neutrophils, the antiviral effect of AgNPs in mice treated was ablated. To our knowledge, this is the first in vivo report demonstrating antiviral activity of AgNPs during RSV infection.

KW - AgNP

KW - Anti-Ly6G

KW - Antiviral

KW - Epithelial cells

KW - G-CSF

KW - GM-CSF

KW - KC

KW - Neutrophils

KW - Respiratory syncytial virus

KW - Silver nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85070476559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070476559&partnerID=8YFLogxK

U2 - 10.3390/v11080732

DO - 10.3390/v11080732

M3 - Article

VL - 11

JO - Viruses

JF - Viruses

SN - 1999-4915

IS - 8

M1 - 732

ER -